North America Cannabidiol Market Outlook, 2030

2025

North America Cannabidiol Market Outlook, 2030

The North America Cannabidiol Market is segmented into By Product Form (Oils & Tinctures, Capsules & Softgels, Gummies & Confectionery, Topicals / Skin Care, Vape Products, Others); By End Use (Wellness & Personal Use, Nutraceuticals & Supplements, Pet Care, Cosmetics & Skin Care, Pharmaceuticals, Food & Beverages); By Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, E-commerce, Medical Dispensaries); By Source (Marijuana, Hemp).

Bonafide Research
31-10-2025
Pages : 89
Figures : 9
Tables : 19
Region : North America
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

North America’s cannabidiol market will grow at 15.10% CAGR (2025–2030), driven by legalization trends, CBD-infused products, and consumer health awareness.

Historical Period2019-2023
Base Year2024
Forecast Period2025-2030
CAGR (2025-2030) 15.1%
Largest Market United States
Fastest Market Canada
Format

Featured Companies

1. Canopy Growth Corporation
2. Jazz Pharmaceuticals plc
3. Elixinol Wellness Limited
4. Aurora Cannabis Inc.
5. Endoca CBD
6. Cronos Group Inc.
More...

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

Cannabidiol Market Analysis

The market for cannabidiol CBD in North America has quickly transformed from a specialized health trend into a major global industry that influences product development and consumer health practices. Initially motivated by changing views on plant-derived treatments, the market's growth aligns with worldwide expansion, establishing North America as a standard for quality, regulation, and technological advancement. The key aim of the CBD market is to provide safe, non-intoxicating health alternatives sourced from hemp, meeting consumer needs for natural remedies for issues like anxiety, pain, inflammation, and sleep difficulties. On a global scale, it connects the precision of pharmaceuticals with holistic health approaches, fostering wider acceptance of therapies based on cannabinoids. The history of the CBD industry begins with the early legalization of hemp and the recognition of cannabidiol's unique therapeutic properties apart from THC. Despite initial obstacles regarding legality, scientific support, and educating consumers, businesses found ways to create a variety of products, including isolates, broad-spectrum, and full-spectrum extracts, each designed to meet different regulatory requirements and consumer preferences. Currently, CBD is commonly found in wellness, beauty, dietary supplements, and pharmaceutical products, appearing in lotions, tinctures, edibles, and skincare items. Scientifically, cannabidiol is a Phyto cannabinoid that interacts with the endocannabinoid system in humans, influencing receptors to enhance balance, decrease inflammation, and promote neurological and immune health. Its ability to ease stress, manage chronic pain, and refresh skin has established its place in preventive health efforts. The growth of the market has been sped up by advancements in technology and research and development refined CO? extraction processes, nano-CBD delivery methods for better absorption, and clinical studies proving safety and effectiveness. These advances, along with efforts for standardization and quality endorsements, have built consumer confidence, leading to widespread use and making North America a leader in the scientific and commercial advancements of the global CBD market. According to the research report, " North America Cannabidiol Market Outlook, 2030," published by Bonafide Research, the North America Cannabidiol market is anticipated to grow at 15.10% CAGR from 2025 to 2030. In recent times, the sector has experienced changes in regulatory guidance from the FDA, the rise of new specialized brands, and growth into main retail outlets. Although the FDA has not completely regulated CBD within traditional drug or dietary supplement guidelines, it frequently sends warning notices to businesses that make unverified health assertions or use misleading labels. Some companies have reacted by prioritizing third-party testing, clear Certificates of Analysis, and cautious advertising. Concurrently, CBD products such as oils, topicals, and edibles are increasingly found in large pharmacy chains, wellness shops, and online marketplaces. Prominent brands like Charlotte’s Web, Medterra, and Green Roads set themselves apart with their formulations and quality measures Charlotte's Web is recognized for its full-spectrum hemp extracts and premium status; Medterra emphasizes strength, specific wellness options, and affordability; Green Roads focuses on pharmacist-recommended formulations and thorough quality checks. There are still significant opportunities ongoing legalization of medical cannabis, an increase in product variety like functional drinks, pet CBD, and beauty products, and clinical support for new medicinal applications. These factors may help broaden the market beyond wellness into medical and specialty sectors. Regarding compliance, several regulations are essential hemp-derived CBD needs to comply with USDA hemp definitions e.g. ? 0.3% THC according to federal agricultural legislation. Quality frameworks such as GMP Good Manufacturing Practices and ISO guidelines are vital for maintaining product consistency, purity, and safety. Strict THC thresholds, thorough labeling regulations, and compliance with FDA-approved claims prevent misbranding and protect consumers. Collectively, these regulations and certifications enhance consumer confidence, reduce regulatory challenges, and support ongoing market expansion in North America.

to Download this information in a PDF

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamic

Market Drivers

• Rising Interest in Natural Health Alternatives:Growing interest among consumers in plant-derived, non-intoxicating treatments has greatly increased the use of CBD in North America. People are turning to CBD for alleviating stress, managing pain, and enhancing sleep quality, leading to its use in wellness, skincare, and dietary products. A rising skepticism towards artificial drugs and concerns regarding opioids have also contributed to this shift toward CBD. With more awareness about products and the availability of online shopping, demand is on the rise across different age groups and lifestyles. This focus on wellness is helping CBD become a common health supplement rather than remaining an obscure option.
• Growing Retail and Distribution Opportunities:Acceptance in mainstream retail has been a significant contributor to the CBD sector's growth. Well-known pharmacy chains, supermarkets, and online marketplaces are now offering CBD products, which improves accessibility and brand awareness. The availability of CBD items in grocery stores, wellness shops, and health food outlets has normalized their usage. Moreover, strategies like direct-to-consumer and subscription services help brands build customer loyalty. The ease of shopping online and clear product evaluations have also increased consumer trust and repeat buying.

Market Challenges

• Unclear Regulations and Gaps in FDA Oversight:The lack of a clear federal regulation framework for CBD continues to present a significant hurdle. The FDA has not yet provided specific guidelines regarding the use of CBD in food, drinks, and nutritional supplements, leading to uncertainty for businesses. This lack of clarity results in uneven enforcement, labeling issues, and restricted market access for newcomers. Many companies are reluctant to make substantial investments due to the risk of regulatory enforcement. Until there is standardization, growth will remain partially limited by compliance challenges and varying state regulations.
• Issues with Quality Assurance and Product Consistency: Although there have been advancements, inconsistencies in quality still pose challenges within the North American CBD market. Some products available can differ in terms of strength, purity, and cannabinoid content. Impurities such as pesticides, heavy metals, or leftover solvents can damage brand reputation. The absence of standard testing protocols makes it difficult for consumers to trust products and affects clinical research. Companies need to prioritize GMP-certified production, involve third-party labs for testing, and provide clear labeling to ensure long-term reliability and stay competitive.

Market Trends

• Advancement in Technology and Product Variety:The sector is quickly changing with improved extraction methods, nano-CBD technologies, and better bioavailability strategies. These developments enhance product effectiveness and attract a wider range of consumers. CBD is also being added to functional drinks, gummies, skin patches, and wellness products for pets. The merger of biotechnology with precise formulations is resulting in a more advanced and scientifically supported product environment. This trend is transitioning CBD from being a novelty item to a vital component of consumer health and wellness.
• Growing Involvement of Medical and Clinical Research: Increasing partnership between CBD manufacturers and research organizations is enhancing scientific verification and public confidence. Research on CBD's effects on anxiety, inflammation, and brain protection is growing, which promotes its acceptance in medicine. The shift towards prescription-strength CBD products is creating a connection between the pharmaceutical sector and the consumer health markets. As more research-based results come to light, insurance companies and healthcare professionals are starting to recognize CBD’s healing capabilities. This movement is likely to raise CBD from merely a lifestyle product to a recognized therapeutic solution.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Cannabidiol Segmentation

By Product Form	Oils & Tinctures
	Capsules & Softgels
	Gummies & Confectionery
	Topicals / Skin Care
	Vape Products
	Others
By End Use	Wellness & Personal Use
	Nutraceuticals & Supplements
	Pet Care
	Cosmetics & Skin Care
	Pharmaceuticals
	Food & Beverages
By Distribution Channel	Hospital & Specialty Pharmacies
	Retail Stores
	E-commerce
	Medical Dispensaries
By Source	Marijuana
	Hemp
North America	United States
	Canada
	Mexico

Oils and tinctures lead the North American cannabidiol market because they provide accurate dosages, quick absorption, adaptability in use, and are viewed as the most genuine and efficient method for delivering CBD. In the North American cannabidiol sector, oils and tinctures constitute the biggest product category due to their outstanding versatility, absorption level, and consumer confidence relative to other CBD products. These items were among the earliest CBD solutions available on the market, which helped establish brand awareness and customer comfort. Oils and tinctures enable accurate dosage management, making them suitable for beginners and therapeutic users looking for steady outcomes. The method of sublingual use facilitates quicker absorption into the bloodstream, resulting in faster effect onset an aspect highly appreciated by users needing relief from anxiety, pain, or sleep issues. Their flexibility has broadened across various areas tinctures can be added to food, drink, or applied externally, providing a multi-functional health option. From the production angle, oils and tinctures are relatively inexpensive to manufacture and simpler to regulate for strength and safety compared to edible products or cosmetics. This has enabled businesses to uphold steady quality, comply with testing regulations, and provide transparency with Certificates of Analysis. The emergence of premium products such as full-spectrum and broad-spectrum oils enhanced with terpenes and minor cannabinoids has further boosted their attractiveness among health-conscious buyers seeking the entourage effect. Furthermore, oils and tinctures align well with the increasing trend of e-commerce and direct consumer sales, as their lightweight and stable characteristics facilitate long-distance distribution and recurring orders. Consumers view tinctures as a more authentic type of CBD more aligned with natural hemp extracts strengthening their reputation for purity and effectiveness. Supported by growing clinical studies confirming the effectiveness of oral CBD and reliable usage recommendations, this product type continues to control North America's market share. As knowledge increases, oils and tinctures are projected to stay fundamental in the region's CBD landscape, connecting traditional wellness with contemporary therapeutic uses. The wellness and personal use sector leads the North American cannabidiol market due to the rising demand from consumers for natural, over-the-counter options for managing stress, alleviating pain, enhancing sleep, and improving general health. In North American cannabidiol CBD market, the wellness and personal use sector holds the largest portion as consumers increasingly focus on preventive health and comprehensive well-being instead of relying on pharmaceuticals. CBD is now closely linked with natural self-care and fits well into the region’s swiftly growing wellness trend. A heightened understanding of CBD’s ability to ease common issues like anxiety, stress, persistent pain, inflammation, and insomnia has driven its popularity among health-aware consumers. The expansion of this market is also indicative of a larger cultural movement towards organic and plant-based goods, with CBD serving as a safe, non-intoxicating option sourced from hemp. This consumer perspective aligns perfectly with wellness and lifestyle movements that highlight balance, recovery, and awareness. The sector is supported by a wide range of product offerings, which include oils, capsules, topical applications, edibles, drinks, and skincare items. Consumers find it convenient to add CBD into their daily habits, whether its tinctures mixed into morning beverages, creams for post-exercise recovery, or gummies consumed before bedtime. The growing acceptance of CBD in the wellness sector has also been bolstered by endorsements from fitness gurus, health coaches, and wellness brands that are including CBD products in their ranges. The spread of retail into pharmacies, beauty retailers, and online wellness sites has improved the availability and reliability of CBD items for everyday shoppers. The easing of regulations for hemp-derived CBD under the U.S. Farm Bill, coupled with a greater focus on product transparency via third-party testing, has further bolstered usage. Innovations in technology, like nano-CBD formulations for quicker absorption, have improved product efficacy and customer satisfaction. The wellness and personal use sector continue to thrive as it represents the primary value of CBD natural, effective, and compatible with healthy lifestyles making it the most applicable and sustainable niche in the North American cannabidiol market. Retail outlets are the quickest expanding distribution method in North America's cannabidiol market as they provide consumers with access to products, confidence in brands, and assurance in purchases through direct interaction and expert advice. In the North American cannabidiol CBD sector, brick-and-mortar shops have become the quickest expanding method of distribution because they connect consumer interest with product reliability. Although online sales were the early leaders in the CBD market, the move towards physical stores has been fueled by a growing demand for trust, openness, and direct experience. Shoppers in this area are increasingly inclined to inspect CBD products face-to-face checking packaging, confirming third-party testing results, and obtaining assistance from knowledgeable staff before buying. This hands-on experience provides reassurance to customers regarding product quality, strength, and safety, which are essential considerations in a market still dealing with regulatory complexities. Key retail chains, such as pharmacies, grocery stores, health shops, and specific CBD retailers, have broadened their offerings to encompass oils, edibles, creams, and products for pets. The presence of CBD items in trusted establishments has normalized their use and appealed to new consumers who might be reluctant to shop online. Retailers serve a significant educational purpose by providing product details and organizing in-store events or consultations, enhancing customers' understanding of usage and advantages. As laws become more consistent and product labeling is standardized, more traditional retailers are collaborating with prominent brands to introduce unique CBD ranges and store-branded products. The incorporation of CBD into everyday retail spaces like organic food stores and cosmetics shops has elevated it from a specialized wellness item to a lifestyle choice. The emergence of blended retail approaches, where physical shops enhance online shopping with loyalty programs and subscription services, further boosts customer loyalty. Thus, retail distribution fosters trust, visibility, and market growth, establishing it as the fastest-growing channel in the CBD market across North America. The combination of ease, education, and confidence positions physical stores as the foundation for CBD's upcoming phase of mainstream acceptance. CBD derived from marijuana is the quickest expanding segment in the North American market because it has greater cannabinoid levels, providing stronger therapeutic benefits that attract both medical and health-conscious buyers. In the cannabidiol CBD market in North America, CBD sourced from marijuana has become the quickest growing segment due to its greater cannabinoid levels and better therapeutic benefits when compared to hemp-derived options. Hemp is still favored for its low THC levels and broad acceptance under regulations; however, marijuana-derived CBD items feature a wider range of cannabinoids, including THC that stays within legal boundaries, which can create the entourage effect. This collaborative effect between cannabinoids and terpenes enhances effectiveness in managing pain, anxiety, and providing neurological support, appealing to consumers in search of stronger health or medicinal alternatives. The expansion of this category is also fueled by the growing legalization and decriminalization of marijuana for both medical and recreational use in various areas of North America. Legal dispensaries make marijuana-derived CBD accessible in a regulated manner, guaranteeing product safety, ensuring strength confirmation, and adhering to state-specific rules. This system of regulations instills confidence in consumers about quality, dosage, and lab-tested products. Furthermore, marijuana-derived CBD items are usually positioned in higher-end categories, attracting discerning buyers who appreciate effectiveness and scientifically validated products. Marijuana-derived CBD promotes innovation, leading to diverse products such as tinctures, edibles, vape oils, topical creams, and concentrates created for specific therapeutic results. The blend of increased cannabinoid diversity and sophisticated extraction methods has sped up consumer acceptance, especially among individuals with chronic conditions and wellness advocates looking for comprehensive solutions. Retail growth and informative initiatives from dispensaries and brands have further boosted awareness and access, strengthened consumer confidence and encouraging repeat purchases. As studies confirm the superior benefits of marijuana-derived CBD and legalization continues to trend upward, this segment seems likely to surpass hemp-derived products in its growth. Its powerful formulation, together with increasing consumer acceptance and clear regulations, positions marijuana-derived CBD as the fastest growing source in North America’s CBD market.

to Download this information in a PDF

Cannabidiol Market Regional Insights

The U.S. is the top market for cannabidiol CBD in North America due to its early legalization, established regulations, high consumer awareness, strong research and development, and extensive retail and online sales. The United States has positioned itself as the foremost market for cannabidiol CBD in North America, propelled by a mix of regulatory developments, consumer acceptance, and industry creativity. The early legalization through the 2018 Farm Bill permitted the legal cultivation and sale of hemp-derived CBD products with under 0.3% THC across the country, laying a solid groundwork for market expansion. This initial regulatory clarity empowered businesses to confidently invest in large-scale manufacturing, research, and marketing efforts, paving the way for U.S. supremacy in regional sales. Moreover, the U.S. has a consumer base that prioritizes health and well-being, leading to a rising interest in natural substitutes for medications aimed at anxiety, pain relief, sleep troubles, and health. Elevated consumer awareness, driven by media attention, endorsements from influencers, and educational initiatives, has boosted CBD acceptance among various demographic groups. The U.S. marketplace is also supported by strong research and development activities, which include clinical studies affirming CBD’s effectiveness, sophisticated extraction methods, and innovative products like nano emulsions and water-soluble forms. These advancements improve bioavailability, safety, and user satisfaction, building consumer trust. Retail and online sales networks in the U.S. are especially well-developed, providing broad access through pharmacies, grocery stores, specialty health shops, and internet businesses, which further enhances market penetration. Leading U.S. companies, such as Charlotte’s Web, Medterra, and Green Roads, have taken advantage of these factors to create strong brand recognition and loyalty, fostering competitive market conditions that promote quality and innovation. The U.S. benefits from extensive compliance standards, including Good Manufacturing Practices GMP, THC limits, and third-party lab testing, which enhance product trustworthiness and consumer assurance. These elements, along with ongoing legalization progress, increasing scientific backing, and a focus on health-centered consumption, place the United States as the key player in North America's CBD market, influencing trends and encouraging growth throughout the area.

to Download this information in a PDF

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Mentioned

Canopy Growth Corporation
Jazz Pharmaceuticals plc
Elixinol Wellness Limited
Aurora Cannabis Inc.
Endoca CBD
Cronos Group Inc.
Tilray Brands, Inc.
Organigram Global Inc.
Isodiol International Inc.
Charlotte's Web Holdings Inc
Medterra CBD, LLC
Cannoid, LLC

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. North America Cannabidiol Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product Form
6.4. Market Size and Forecast, By End Use
6.5. Market Size and Forecast, By Distribution Channel
6.6. Market Size and Forecast, By Source
6.7. United States Cannabidiol Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Product Form
6.7.3. Market Size and Forecast By End Use
6.7.4. Market Size and Forecast By Source
6.8. Canada Cannabidiol Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Product Form
6.8.3. Market Size and Forecast By End Use
6.8.4. Market Size and Forecast By Source
6.9. Mexico Cannabidiol Market Outlook
6.9.1. Market Size by Value
6.9.2. Market Size and Forecast By Product Form
6.9.3. Market Size and Forecast By End Use
6.9.4. Market Size and Forecast By Source
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Key Players Market Positioning Matrix
7.4. Porter's Five Forces
7.5. Company Profile
7.5.1. Canopy Growth Corporation
7.5.1.1. Company Snapshot
7.5.1.2. Company Overview
7.5.1.3. Financial Highlights
7.5.1.4. Geographic Insights
7.5.1.5. Business Segment & Performance
7.5.1.6. Product Portfolio
7.5.1.7. Key Executives
7.5.1.8. Strategic Moves & Developments
7.5.2. Jazz Pharmaceuticals plc
7.5.3. Elixinol Wellness Limited
7.5.4. Aurora Cannabis Inc.
7.5.5. Endoca CBD
7.5.6. Cronos Group Inc.
7.5.7. Tilray Brands, Inc.
7.5.8. Organigram Global Inc.
7.5.9. Isodiol International Inc.
7.5.10. Charlotte's Web Holdings Inc
7.5.11. Medterra CBD, LLC
7.5.12. Cannoid, LLC
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
9.3. Related Reports
10. Disclaimer

Table 1: Global Cannabidiol Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
Table 2: Influencing Factors for Cannabidiol Market, 2024
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: North America Cannabidiol Market Size and Forecast, By Product Form (2019 to 2030F) (In USD Billion)
Table 7: North America Cannabidiol Market Size and Forecast, By End Use (2019 to 2030F) (In USD Billion)
Table 8: North America Cannabidiol Market Size and Forecast, By Distribution Channel (2019 to 2030F) (In USD Billion)
Table 9: North America Cannabidiol Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 10: United States Cannabidiol Market Size and Forecast By Product Form (2019 to 2030F) (In USD Billion)
Table 11: United States Cannabidiol Market Size and Forecast By End Use (2019 to 2030F) (In USD Billion)
Table 12: United States Cannabidiol Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 13: Canada Cannabidiol Market Size and Forecast By Product Form (2019 to 2030F) (In USD Billion)
Table 14: Canada Cannabidiol Market Size and Forecast By End Use (2019 to 2030F) (In USD Billion)
Table 15: Canada Cannabidiol Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 16: Mexico Cannabidiol Market Size and Forecast By Product Form (2019 to 2030F) (In USD Billion)
Table 17: Mexico Cannabidiol Market Size and Forecast By End Use (2019 to 2030F) (In USD Billion)
Table 18: Mexico Cannabidiol Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 19: Competitive Dashboard of top 5 players, 2024

Figure 1: Global Cannabidiol Market Size (USD Billion) By Region, 2024 & 2030
Figure 2: Market attractiveness Index, By Region 2030
Figure 3: Market attractiveness Index, By Segment 2030
Figure 4: North America Cannabidiol Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 5: North America Cannabidiol Market Share By Country (2024)
Figure 6: US Cannabidiol Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 7: Canada Cannabidiol Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 8: Mexico Cannabidiol Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 9: Porter's Five Forces of Global Cannabidiol Market

Cannabidiol Market Research FAQs

Growth in this sector is mainly fueled by an increasing consumer interest in natural health products, the ongoing legalization of CBD derived from hemp, a greater awareness of the health benefits.

Oils and tinctures are the leading products in the market due to their accurate dosing, quick absorption, adaptability for different uses, and high level of consumer confidence.

Prominent businesses include Charlotte’s Web, Medterra, and Green Roads.

Major obstacles encompass unclear regulations at the national level, inconsistent labeling practices, issues with quality control, and fluctuations in product potency.

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted